Favorite this paper
How to cite this paper?
Abstract

Synthetic organic chemistry plays a fundamental role in the development of new therapeutic agents. Malaria is a life-threatening disease transmitted by the bite of infected Anopheles mosquitoes. In 2024, the malaria burden resulted in 210 million cases and 610 thousand deaths.1 The demand for new chemotherapies for malaria treatment has risen due to the development of drug resistance emerging worldwide.2 In this work, amide-pyrazole analogs are synthetized by a 5-step parallel-convergent route to afford derivatives with antiplasmodial activity. An aniline derivative is converted to hydrazine via a phenyldiazonium chloride as intermediate. In parallel, dioxopentanoates are synthesized to allow pyrazole formation by Knorr cyclization.3 Curtius’ rearrangement furnishes the substrate for amide coupling with carboxylic acids, providing an average global yield of 7%.4 Three distinct molecular cores were explored, with synthetic adaptation required for central core functionalization. Around 40 analogs were synthesized, reaching potency enhancement.

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 Institute of Chemistry (IQ), State University of Campinas (UNICAMP)
  • 2 São Carlos Institute of Physics, University of São Paulo (USP)
  • 3 Medicines for Malaria Venture
Track
  • BMOS-2026
Keywords
pyrazole
amide coupling
malaria
Knorr cyclization
drug discovery